Skip to main content

Option Care Health Value Stock - Dividend - Research Selection

Bioscrip

ISIN: US68404L2016 , WKN: A2PZEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Is It Too Late to Consider Option Care Health After Its 43% 2025 Rally?

2025-12-22
If you have been wondering whether Option Care Health is still good value after its big run, you are not alone. Let's break down what the market may be pricing in. The stock is up 43.2% year to date and 41.8% over the last year, even after a recent 3.1% pullback in the past week and a 9.9% gain over the last month. This suggests sentiment is still broadly bullish but getting more selective. Investors have been reacting to a mix of strategic updates and sector wide optimism around home and...

Zacks Industry Outlook Highlights Encompass Health, DaVita, Option Care Health and The Pennant

2025-12-22
Encompass Health is in focus as outpatient and home healthcare shifts toward AI, telehealth and cost-efficient care models.

4 Outpatient Home Health Stocks in Focus as Market Dynamics Change

2025-12-19
An aging population and rising AI adoption position the Zacks Medical - Outpatient and Home Healthcare industry for solid growth. EHC, DVA, OPCH and PNTG stand to benefit.

2 Unpopular Stocks That Should Get More Attention and 1 Facing Challenges

2025-12-19
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

3 Stocks Under $50 We Approach with Caution

2025-12-15
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

Option Care Health to Participate in the J.P. Morgan Healthcare Conference

2025-12-12
BANNOCKBURN, Ill., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the 44th Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Tuesday, January 13, 2026, including a presentation at 10:30am PT. The webcast and related presentation materials will be available online at https://investors.optioncarehealth.com. About Opti

Option Care Health (OPCH) Valuation After Analyst Upgrades and Reaffirmed Long-Term Growth Targets

2025-12-11
Option Care Health (OPCH) just caught a meaningful wave of analyst optimism after management doubled down on its long term growth goals, helping push the stock higher and putting its infusion focused model back in the spotlight. See our latest analysis for Option Care Health. The latest pop in OPCH adds to an already strong run, with a roughly mid teens 3 month share price return feeding into a near 46 percent share price gain year to date and a more than 120 percent 5 year total shareholder...

The 6.5% return this week takes Option Care Health's (NASDAQ:OPCH) shareholders five-year gains to 123%

2025-12-10
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

3 Low-Volatility Stocks with Open Questions

2025-12-10
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Why Option Care Health (OPCH) Stock Is Up Today

2025-12-09
Shares of alternate site health provider Option Care Health (NASDAQ:OPCH) jumped 4.7% in the morning session after the company received positive commentary from multiple financial analysts, including price target increases from Deutsche Bank and BofA Securities. Deutsche Bank raised its price target on the stock to $36 from $31, while keeping a Buy rating. Similarly, BofA Securities lifted its target to $35 from $32 and also maintained its Buy rating. The move from BofA followed a conference whe